Key Points
VENI.CN trades at C$0.005 with 99.2% decline from highs
Meyka AI rates stock B- with hold recommendation
Severe profitability losses and negative cash flow create distress
Extreme oversold conditions lack recovery catalysts
Vencanna Ventures Inc. (VENI.CN) trades at C$0.005 on the CNQ exchange, reflecting significant pressure in the cannabis capital sector. The Calgary-based company provides funding for early-stage global cannabis initiatives but faces substantial headwinds. With a market cap of C$1.11 million and 222.6 million shares outstanding, VENI.CN stock shows extreme illiquidity and negative fundamentals. Meyka AI rates VENI.CN with a B- grade, suggesting a hold position. The stock has declined 99.2% from its all-time high, making it one of the market’s most distressed equities. Despite the challenges, some investors monitor oversold positions for potential recovery plays.
VENI.CN Stock Performance and Valuation Metrics
VENI.CN stock trades at rock-bottom levels with minimal daily volume. The stock has remained flat at C$0.005 with zero daily change, while average volume sits at just 5,426 shares. Year-to-date performance shows no movement, but the 6-month decline of 50% and 3-year drop of 91.67% reveal persistent weakness. The price-to-book ratio of 0.34 suggests the stock trades below tangible asset value, a potential value signal for contrarian investors.
Liquidity and Trading Conditions
Trading activity in VENI.CN remains extremely thin. Recent volume of 4,000 shares represents just 0.07% of average daily volume, indicating severe liquidity constraints. The 52-week range spans C$0.005 to C$0.015, with the stock anchored at the low end. This illiquidity makes entry and exit difficult for institutional investors, keeping VENI.CN confined to retail and speculative traders only.
Financial Health and Profitability Challenges
Vencanna Ventures faces severe profitability headwinds that justify the depressed valuation. The company reports a negative EPS of -C$0.01 and a negative ROE of -87.46%, indicating shareholder value destruction. Revenue per share stands at just C$0.0115, while net income per share is -C$0.0118, showing the company burns cash faster than it generates revenue. The net profit margin of -102.6% reveals operational losses exceed total revenue.
Cash Flow and Debt Concerns
Operating cash flow per share is -C$0.0018, while free cash flow per share is -C$0.0026, confirming ongoing cash burn. The current ratio of 0.38 signals liquidity stress, as current liabilities exceed current assets by 2.6 times. Working capital stands at -C$988,172, a massive deficit that threatens operational continuity. Debt-to-equity of 0.19 remains manageable, but negative earnings make debt service increasingly difficult.
Market Sentiment and Technical Positioning
Technical indicators for VENI.CN stock show neutral to bearish signals with minimal momentum. The RSI of 0.00 indicates extreme oversold conditions, yet this has not triggered a recovery. The MACD, momentum, and ROC all read 0.00, suggesting the stock has stalled completely. Bollinger Bands and Keltner Channels converge at C$0.01, showing price compression and low volatility. The Money Flow Index of 50 reflects balanced but minimal trading activity.
Trading Activity and Liquidation Pressure
Track VENI.CN on Meyka for real-time updates on this distressed equity. Volume remains depressed at 4,000 shares, well below the 5,426-share average. The stock’s extreme oversold status combined with zero momentum suggests capitulation selling may have ended, but recovery catalysts remain absent. Institutional investors have largely abandoned the position, leaving only retail holders and speculators.
Meyka AI Grade and Forecast Outlook
Meyka AI rates VENI.CN with a B- grade and a hold recommendation, based on comprehensive fundamental analysis. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating reflects mixed signals: strong valuation metrics (P/B of 0.34) offset by severe profitability losses and negative cash flow. These grades are not guaranteed and we are not financial advisors.
Price Forecast and Upside Potential
Meyka AI’s forecast model projects C$0.01 quarterly earnings with limited upside from current levels. The quarterly forecast implies a 100% upside from the current C$0.005 price, though this remains speculative. Annual forecasts show C$0.00, suggesting minimal near-term recovery. Forecasts are model-based projections and not guarantees. The company must stabilize operations and return to profitability before meaningful price appreciation occurs.
Final Thoughts
VENI.CN stock trades at distressed levels reflecting fundamental deterioration in Vencanna Ventures’ cannabis capital business. The C$0.005 price point with 99.2% decline from highs signals severe shareholder value destruction. Negative profitability, cash burn, and liquidity stress create a challenging investment backdrop. However, the B- Meyka grade and extreme valuation metrics suggest some investors see contrarian opportunity. The stock remains highly speculative and illiquid, suitable only for risk-tolerant traders monitoring oversold bounces. Recovery requires operational turnaround, return to profitability, and renewed investor interest in cannabis capital funding. Unti…
FAQs
VENI.CN trades at C$0.005 due to severe profitability losses, negative cash flow, and liquidity stress. The company burns cash faster than generating revenue, with a -102.6% net profit margin. Shareholder value destruction and weak investor interest drove the stock down 99.2%.
The B- grade with hold recommendation reflects mixed fundamentals: attractive valuation offset by severe losses and negative cash flow. It considers S&P benchmarks, sector performance, financial growth, and analyst consensus, suggesting caution rather than strong conviction.
VENI.CN shows extreme oversold conditions with RSI at 0.00 and minimal momentum, but lacks recovery catalysts. With only 4,000 daily shares trading, recovery requires operational turnaround and profitability return, making it highly speculative.
Vencanna Ventures provides capital for early-stage global cannabis initiatives. The Calgary-based company, founded in 1989, operates in drug manufacturing. However, negative earnings and cash burn indicate the capital provision strategy has not generated shareholder returns.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)